Prestige BioPharma announced positive top-line results from a phase III global clinical trial (Troika) evaluating the efficacy, safety, and pharmacokinetics of biosimilar candidate HD201 to Herceptin (trastuzumab).
Multiple components of the healthcare and public health systems are currently under scrutiny. One of them is reportedly the U.S. Preventive Services Task Force (USPSTF: “Task Force”), established in 1984 and managed by the Agency for Healthcare Research and Quality. It was created to maintain an ongoing evaluation of disease prevention and screening interventions that...
